Oppenheimer Reiterates Outperform on Humana, Maintains $630 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on Humana (NYSE:HUM) and maintained a price target of $630.
January 17, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer maintains an Outperform rating and a $630 price target for Humana, indicating a positive outlook for the stock.
The reiteration of an Outperform rating by a reputable analyst like Michael Wiederhorn suggests a strong conviction in the company's future performance. This could positively influence investor sentiment and potentially drive the stock price up in the short term, especially if the market consensus aligns with this viewpoint.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100